Hikma shares rally after US launch of Advair generic resumes

Shares in Hikma have rallied as it resumed the launch of its generic Advair Diskus in the US, after clearing up a final piece of bureaucracy with the FDA. The London-listed firm is one of several companies that had been trying to make generics of GlaxoSmithKline’s former respiratory diseases blockbuster for the US market. Advair …

Hikma shares rally after US launch of Advair generic resumes Read More »